Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-07-30

Clinical Trial Update: Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated adding Remune to participants' existing antiretroviral therapy for HIV infection; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remune

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: TERMINATED